Tower Research Capital (TRC)’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Tower Research Capital (TRC)’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,797	Closed	-$5.35K	–	6409
2023 Q3	$5.35K	Sell	1,797 -1,127	-39%	-$2.63K	﹤0.01%	4732
2023 Q2	$7.11K	Sell	2,924 -2,550	-47%	-$4.2K	﹤0.01%	4619
2023 Q1	$9K	Buy	+5,474	New	+$12.4K	﹤0.01%	4598
2022 Q4	–	Sell	-186	Closed	-$1K	–	6867
2022 Q3	$1K	Buy	+186	New	+$1.56K	﹤0.01%	5987
2022 Q1	–	Sell	-164	Closed	-$3K	–	7028
2021 Q4	$3K	Sell	164 -87	-35%	-$2.47K	﹤0.01%	5568
2021 Q3	$11K	Buy	251 +233	+1,294%	+$11.4K	﹤0.01%	4287
2021 Q2	$1K	Sell	18 -26	-59%	-$1.83K	﹤0.01%	5356
2021 Q1	$5K	Buy	+44	New	+$3.79K	﹤0.01%	4728
2020 Q4	–	Sell	-19	Closed	-$1K	–	5517
2020 Q3	$1K	Buy	+19	New	+$1.53K	﹤0.01%	4764

Tower Research Capital (TRC)'s TMBR Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2023, closing a stake of 1,797 shares — an estimated $5.35K sold.

Tower Research Capital (TRC) first reported a position in TMBR in Q3 2020 and held it in 9 quarters. The position peaked at $11K in Q3 2021. 0 funds tracked by Wall St. Rank hold TMBR as of Q4 2023.

Tower Research Capital (TRC) reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,797 Timber Pharmaceuticals, Inc. shares in Q4 2023, an estimated $5.35K.
Tower Research Capital (TRC) first reported a position in Timber Pharmaceuticals, Inc. in Q3 2020 and held it in 9 quarters.
Tower Research Capital (TRC)'s Timber Pharmaceuticals, Inc. position peaked at $11K in Q3 2021.
0 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.